
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 184
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 184
Showing 1-25 of 184 citing articles:
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 435-442
Closed Access | Times Cited: 34
Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 435-442
Closed Access | Times Cited: 34
SERS in 3D cell models: a powerful tool in cancer research
Lara Troncoso-Afonso, Gail A. Vinnacombe‐Willson, Clara García‐Astrain, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 5118-5148
Open Access | Times Cited: 17
Lara Troncoso-Afonso, Gail A. Vinnacombe‐Willson, Clara García‐Astrain, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 5118-5148
Open Access | Times Cited: 17
ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer
Li‐Ping Ge, Xi Jin, Ding Ma, et al.
Cell Research (2024) Vol. 34, Iss. 1, pp. 58-75
Closed Access | Times Cited: 12
Li‐Ping Ge, Xi Jin, Ding Ma, et al.
Cell Research (2024) Vol. 34, Iss. 1, pp. 58-75
Closed Access | Times Cited: 12
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
Qiuqiang Chen, Gang Jia, Xilin Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 10
Qiuqiang Chen, Gang Jia, Xilin Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 10
Recent advances in breast cancer cell line research
Manika P Sharma, Supriya Shukla, Gauri Misra
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1683-1693
Closed Access | Times Cited: 10
Manika P Sharma, Supriya Shukla, Gauri Misra
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1683-1693
Closed Access | Times Cited: 10
CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer
Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 10
Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 10
Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
Tianqi Luo, Zhijin Fan, Anyu Zeng, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 10
Tianqi Luo, Zhijin Fan, Anyu Zeng, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 10
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
SILK FIBROIN-COATED MESOPOROUS SILICA NANOPARTICLES ENHANCE 6-THIOGUANINE DELIVERY AND CYTOTOXICITY IN BREAST CANCER CELLS
MOHAMMAD AMIN KABOLI, ALAA A. HASHIM, Dhiya Altememy, et al.
International Journal of Applied Pharmaceutics (2025), pp. 275-283
Open Access | Times Cited: 1
MOHAMMAD AMIN KABOLI, ALAA A. HASHIM, Dhiya Altememy, et al.
International Journal of Applied Pharmaceutics (2025), pp. 275-283
Open Access | Times Cited: 1
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
The importance of preclinical models for cholangiocarcinoma drug discovery
Florian Primavesi, Felix J. Krendl, Rupert Oberhuber, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access | Times Cited: 1
Florian Primavesi, Felix J. Krendl, Rupert Oberhuber, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access | Times Cited: 1
Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application
Éva Márton, Alexandra Varga, Dóra Domoszlai, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 579-579
Open Access | Times Cited: 1
Éva Márton, Alexandra Varga, Dóra Domoszlai, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 579-579
Open Access | Times Cited: 1
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy
Ian Sarvary, Mikkel Vestergaard, Loris Moretti, et al.
Journal of Medicinal Chemistry (2025)
Open Access | Times Cited: 1
Ian Sarvary, Mikkel Vestergaard, Loris Moretti, et al.
Journal of Medicinal Chemistry (2025)
Open Access | Times Cited: 1
The techniques and applications of patient-derived head and neck cancer organoids: a systematic review
Yangyang Xia, Shang Xie, Zhigang Cai, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Yangyang Xia, Shang Xie, Zhigang Cai, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22
Experimental Murine Models for Colorectal Cancer Research
Íris Neto, João Rocha, Maria Manuela Gaspar, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2570-2570
Open Access | Times Cited: 17
Íris Neto, João Rocha, Maria Manuela Gaspar, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2570-2570
Open Access | Times Cited: 17
Basic models to advanced systems: harnessing the power of organoids-based microphysiological models of the human brain
Katherine Boylin, Grace V. Aquino, Michael Purdon, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032007-032007
Open Access | Times Cited: 8
Katherine Boylin, Grace V. Aquino, Michael Purdon, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032007-032007
Open Access | Times Cited: 8
Vaccine-based immunotherapy and related preclinical models for glioma
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 8
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 8
Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application
Chong Gao, Jianping Jiang, Jing Zhao, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216109-216109
Open Access | Times Cited: 8
Chong Gao, Jianping Jiang, Jing Zhao, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216109-216109
Open Access | Times Cited: 8
Organoid: Bridging the gap between basic research and clinical practice
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 16
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 16
Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish
Sharad S. Singhal, Rachana Garg, Atish Mohanty, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2961-2961
Open Access | Times Cited: 15
Sharad S. Singhal, Rachana Garg, Atish Mohanty, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2961-2961
Open Access | Times Cited: 15
Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
Weijing Wang, Yongshu Li, Kaida Lin, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 5, pp. 381-398
Open Access | Times Cited: 14
Weijing Wang, Yongshu Li, Kaida Lin, et al.
Animal Models and Experimental Medicine (2023) Vol. 6, Iss. 5, pp. 381-398
Open Access | Times Cited: 14
Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance
Tianying Yuan, Xihong Fu, Rongcheng Hu, et al.
Trends in biotechnology (2024) Vol. 42, Iss. 11, pp. 1523-1550
Closed Access | Times Cited: 6
Tianying Yuan, Xihong Fu, Rongcheng Hu, et al.
Trends in biotechnology (2024) Vol. 42, Iss. 11, pp. 1523-1550
Closed Access | Times Cited: 6
The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
Venkatachalababu Janitri, K.N. ArulJothi, Vijay Murali Ravi Mythili, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Venkatachalababu Janitri, K.N. ArulJothi, Vijay Murali Ravi Mythili, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6